• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Novel microfluidic device for measurable residual disease detection in acute leukemia.用于检测急性白血病可测量残留病的新型微流控装置。
Innovation (Camb). 2023 Mar 5;4(3):100408. doi: 10.1016/j.xinn.2023.100408. eCollection 2023 May 15.
2
Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia.靶向 RNA 测序用于急性髓系白血病微小残留病的定量检测。
Haematologica. 2019 Feb;104(2):297-304. doi: 10.3324/haematol.2018.203133. Epub 2018 Aug 31.
3
Measurable Residual Disease Detection in B-Acute Lymphoblastic Leukemia: The Children's Oncology Group (COG) Method.B 急性淋巴细胞白血病的可测量残留病灶检测：儿童肿瘤学组（COG）方法。
Curr Protoc. 2022 Mar;2(3):e383. doi: 10.1002/cpz1.383.
4
Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia.浆细胞样树突状细胞分化缺失对急性髓系白血病诱导后可测量残留病高度预测，并与不良预后相关。
Haematologica. 2019 Jul;104(7):1378-1387. doi: 10.3324/haematol.2018.203018. Epub 2018 Dec 6.
5
Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.基于数字液滴 PCR 的移植前 NPM1 突变负担绝对定量可预测急性髓系白血病患者的复发。
Ann Hematol. 2018 Oct;97(10):1757-1765. doi: 10.1007/s00277-018-3373-y. Epub 2018 May 22.
6
[Significance of detecting minimal/measurable residual disease utilizing genetic mutations in acute myeloid leukemia].[利用基因突变检测急性髓系白血病微小/可测量残留病的意义]
Rinsho Ketsueki. 2020;61(8):965-970. doi: 10.11406/rinketsu.61.965.
7
Measurable Residual Disease Testing in Acute Leukemia: Technology and Clinical Significance急性白血病中的可测量残留病检测：技术与临床意义
8
Highly Sensitive Minimal Residual Disease Detection by Biomimetic Multivalent Aptamer Nanoclimber Functionalized Microfluidic Chip.仿生多价适体纳米攀爬器功能化微流控芯片高灵敏度微量残留疾病检测。
Small. 2020 May;16(20):e2000949. doi: 10.1002/smll.202000949. Epub 2020 Apr 22.
9
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing.从诊断到移植后随访的急性髓系白血病中的可测量残留病和克隆进化：下一代测序的作用
Biomedicines. 2023 Jan 26;11(2):359. doi: 10.3390/biomedicines11020359.
10
Minimal/Measurable Residual Disease Detection in Acute Leukemias by Multiparameter Flow Cytometry.多参数流式细胞术检测急性白血病中的微小/可测量残留病
Curr Hematol Malig Rep. 2018 Dec;13(6):455-466. doi: 10.1007/s11899-018-0479-1.

引用本文的文献

1
Artificial intelligence-based predictive model for relapse in acute myeloid leukemia patients following haploidentical hematopoietic cell transplantation.基于人工智能的单倍体造血细胞移植后急性髓系白血病患者复发预测模型。
J Transl Int Med. 2025 Jun 20;13(3):253-266. doi: 10.1515/jtim-2025-0028. eCollection 2025 Jun.
2
monitoring before and after allogeneic haematopoietic stem cell transplantation for acute myeloid leukemia: A report from the TROPHY study group.急性髓系白血病异基因造血干细胞移植前后的监测：TROPHY研究组报告
J Transl Int Med. 2025 Jul 31;13(4):375-385. doi: 10.1515/jtim-2025-0032. eCollection 2025 Aug.
3
Venetoclax and azacitidine compared with intensive chemotherapy for adverse-risk acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation in first complete remission: A multicenter study of TROPHY group.维奈托克与阿扎胞苷对比强化化疗用于首次完全缓解后接受异基因造血干细胞移植的高危急性髓系白血病患者：TROPHY组的多中心研究
Chin J Cancer Res. 2025 Jun 30;37(3):417-431. doi: 10.21147/j.issn.1000-9604.2025.03.10.
4
Identification and validation of the common pathogenesis and hub biomarkers in Papillary thyroid carcinoma complicated by rheumatoid arthritis.甲状腺乳头状癌合并类风湿关节炎的共同发病机制及核心生物标志物的鉴定与验证
PLoS One. 2025 Mar 10;20(3):e0317369. doi: 10.1371/journal.pone.0317369. eCollection 2025.
5
Pre-transplantation levels of lysine (K)-specific methyltransferase 2A () partial tandem duplications can predict relapse of acute myeloid leukemia patients following haploidentical donor hematopoietic stem cell transplantation.移植前赖氨酸（K）特异性甲基转移酶2A（）部分串联重复水平可预测单倍体相合供者造血干细胞移植后急性髓系白血病患者的复发情况。
Blood Sci. 2024 Sep 25;6(4):e00207. doi: 10.1097/BS9.0000000000000207. eCollection 2024 Oct.
6
Identifying crucial lncRNAs and mRNAs in hypoxia-induced A549 lung cancer cells and investigating their underlying mechanisms via high-throughput sequencing.通过高通量测序鉴定低氧诱导的 A549 肺癌细胞中的关键 lncRNAs 和 mRNAs 并研究其潜在机制。
PLoS One. 2024 Sep 5;19(9):e0307954. doi: 10.1371/journal.pone.0307954. eCollection 2024.
7
Hepatic encephalopathy post-TIPS: Current status and prospects in predictive assessment.经颈静脉肝内门体分流术后肝性脑病：预测评估的现状与前景
Comput Struct Biotechnol J. 2024 Jul 10;24:493-506. doi: 10.1016/j.csbj.2024.07.008. eCollection 2024 Dec.
8
Single-cell immune landscape of measurable residual disease in acute myeloid leukemia.急性髓系白血病中可测量残留病的单细胞免疫景观。
Sci China Life Sci. 2024 Nov;67(11):2309-2322. doi: 10.1007/s11427-024-2666-8. Epub 2024 Jul 19.
9
The clinical value of nutritional and inflammatory indicators in predicting pneumonia among patients with intracerebral hemorrhage.营养和炎症指标在预测脑出血患者肺炎中的临床价值。
Sci Rep. 2024 Jul 13;14(1):16171. doi: 10.1038/s41598-024-67227-y.
10
Predictive value of inflammatory prognostic index for contrast-induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.炎症性预后指数对行冠状动脉造影和/或经皮冠状动脉介入治疗的患者对比剂肾病的预测价值。
Sci Rep. 2024 Jul 9;14(1):15861. doi: 10.1038/s41598-024-66880-7.

本文引用的文献

1
Fast, Reusable, Cell Uniformly Distributed Membrane Filtration Device for Separation of Circulating Tumor Cells.用于分离循环肿瘤细胞的快速、可重复使用、细胞均匀分布的膜过滤装置
ACS Omega. 2022 Jun 8;7(24):20761-20767. doi: 10.1021/acsomega.2c01153. eCollection 2022 Jun 21.
2
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.2021 年急性髓系白血病微小残留病更新：来自欧洲白血病网微小残留病工作组的共识文件。
Blood. 2021 Dec 30;138(26):2753-2767. doi: 10.1182/blood.2021013626.
3
A novel microfluidic device integrating focus-separation speed reduction design and trap arrays for high-throughput capture of circulating tumor cells.一种集成聚焦-分离减速设计和捕获阵列的新型微流控装置，用于高通量捕获循环肿瘤细胞。
Lab Chip. 2020 Nov 10;20(22):4094-4105. doi: 10.1039/d0lc00631a.
4
Liquid biopsy and minimal residual disease - latest advances and implications for cure.液体活检与微小残留病灶——最新进展及其对治愈的影响。
Nat Rev Clin Oncol. 2019 Jul;16(7):409-424. doi: 10.1038/s41571-019-0187-3.
5
Preventing relapse after haematopoietic stem cell transplantation for acute leukaemia: the role of post-transplantation minimal residual disease (MRD) monitoring and MRD-directed intervention.预防急性白血病造血干细胞移植后的复发：移植后微小残留病（MRD）监测及MRD导向干预的作用
Br J Haematol. 2017 Oct;179(2):184-197. doi: 10.1111/bjh.14778. Epub 2017 May 23.

Novel microfluidic device for measurable residual disease detection in acute leukemia.

作者信息

Cai Ziwei, Fan Shuang, Sun Xiaoyi, Mo Xiaodong, Yang Gen

机构信息

State Key Laboratory of Nuclear Physics and Technology, School of Physics, Peking University, Beijing 100871, China.

Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.

出版信息

Innovation (Camb). 2023 Mar 5;4(3):100408. doi: 10.1016/j.xinn.2023.100408. eCollection 2023 May 15.

DOI:10.1016/j.xinn.2023.100408
PMID:37008987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10060743/
Abstract
摘要